Skip to content
  • About Us
    • Home
    • About Editor -in-Chief
  • INTERNATIONAL
    • International
  • Bureaucracy Updates
    • PSU
  • Current News
  • State
  • Corporate
  • Central Government Schemes
  • Latest News
  • Excl. Interviews
  • Post your coverages
  • About Editor -in-Chief
  • Converse with Tarun – Exclusive Video interviews
  • Health & Fitness
    • Health & Fitness
  • Advertise with us
  • PSU
  • Diplomacy News
  • Events
TOP INDIAN BUREAUCRACY NEWS | SARKARIMIRROR

TOP INDIAN BUREAUCRACY NEWS | SARKARIMIRROR

India’s top bureaucracy news portal, read the latest insider from the world of bureaucracy, politics, PSUs, defence and corporate, updated round the clock

  • About Us
    • Home
    • About Editor -in-Chief
  • INTERNATIONAL
    • International
  • Bureaucracy Updates
    • PSU
  • Current News
  • State
  • Corporate
  • Central Government Schemes
  • Latest News
  • Excl. Interviews
  • Post your coverages
  • About Editor -in-Chief
  • Converse with Tarun – Exclusive Video interviews
  • Health & Fitness
    • Health & Fitness
  • Advertise with us
  • PSU
  • Diplomacy News
  • Events

Flash News

Government Strengthens Public Sector Banks Through Strategic Workforce Expansion

Raksha Mantri holds bilateral talks with Italian Defence Minister in New Delhi

Prime Minister attends the Heads of Missions Conference in New Delhi

First Preparatory Meeting of  BRICS Women’s Working Group convened by Ministry of Women and Child Development

Friday, May 01, 2026

Tag: including multiple sclerosis

GLAXO SMITHKLINE SELLS RIGHTS TO NOVARTIS AG OF DRUG USED IN TREATING AUTOIMMUNE DISEASES
Corporate

GLAXO SMITHKLINE SELLS RIGHTS TO NOVARTIS AG OF DRUG USED IN TREATING AUTOIMMUNE DISEASES

sarkarimirror August 22, 2015

LONDON—  GlaxoSmithKline PLC is selling its remaining rights to a drug for use in treating autoimmune diseases, including multiple sclerosis, to Novartis  AG for up to $1 billion, plus royalties. Glaxo … Read More

as the drug is knowngalxo smithklinegskincluding multiple sclerosisLONDON— GlaxoSmithKlinePLC is selling its remaining rights to a drug for use in treating autoimmune diseasesplus royalties. Glaxo said on Friday that Novartis will own rights to ofatumumabto Novartis AG for up to $1 billion

Tarun Sharma, Editor-in- Chief

May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Apr    

Informative Links

SGRH LOGO
dmrc routes and fares
Screenshot 2020 07 08 10 21 51 637 Com.google.android.apps.docs

INFORMATIVE LINKS

Proudly powered by WordPress | Theme: TimesNews | By Theme Freesia.